英国国家卒中临床指南2023版要点及解读——短暂性脑缺血发作及轻型缺血性卒中

doi:10.3969/j.issn.1673-5765.2023.12.003

摘要/Abstract

摘要： TIA是局部脑或视网膜缺血引起的短暂性神经功能缺损，症状持续时间短于24 h。轻型卒中通常以NIHSS评分≤5分或NIHSS评分≤3分作为判断标准。英国国家卒中临床指南2023版对TIA及轻型缺血性卒中的诊断、治疗、预防及管理提出了详细的推荐意见，本文对这部分推荐进行解读，并对其中与英国国家卒中临床指南2016版相比的更新要点进行重点分析。

关键词: 短暂性脑缺血发作；轻型卒中；指南推荐

Abstract: TIA is a transient neurological impairment caused by local cerebral or retinal ischemia, with symptoms lasting less than 24 hours. Minor stroke is usually measured by NIHSS score≤5 or NIHSS score≤3. The 2023 edition of the National Clinical Guideline for Stroke for the United Kingdom and Ireland provided detailed recommendations for the diagnosis, treatment, prevention and management of TIA and minor stroke. This paper provides an interpretation of these recommendations and highlights the updates compared with the 2016 edition of the National Clinical Guideline for Stroke for the United Kingdom and Ireland.

Key words: Transient ischemic attack; Minor stroke; Guideline recommendation

中图分类号:

马瑛, 路正钊, 王拥军. 英国国家卒中临床指南2023版要点及解读——短暂性脑缺血发作及轻型缺血性卒中[J]. 中国卒中杂志, 2023, 18(12): 1352-1356.

MA Ying, LU Zhengzhao, WANG Yongjun. Interpretation of the Keypoints and Updates on National Clinical Guideline for Stroke for the United Kingdom and Ireland (Edition 2023) —Transient Ischemic Attack and Minor Stroke[J]. Chinese Journal of Stroke, 2023, 18(12): 1352-1356.

参考文献

[1] AMARENCO P，LAVALLÉE P C，LABREUCHE J，et al. One-year risk of stroke after transient ischemic attack or minor stroke[J/OL]. N Engl J Med，2016，374（16）：1533-1542[2023-07-21]. https://doi.org/10.1056/NEJMoa1412981.
[2] ILDSTAD F，ELLEKJÆR H，WETHAL T，et al. ABCD3-I and ABCD2 Scores in a TIA population with low stroke risk[J/OL]. Stroke Res Treat，2021，2021：8845898[2023-07-21]. https://doi.org/10.1155/2021/8845898.
[3] MERWICK A，ALBERS G W，AMARENCO P，et al. Addition of brain and carotid imaging to the ABCD2 score to identify patients at early risk of stroke after transient ischaemic attack：a multicentre observational study[J]. Lancet Neurol，2010，9（11）：1060-1069.
[4] LAVALLÉE P C，MESEGUER E，ABBOUD H，et al. A transient ischaemic attack clinic with round-the-clock access（SOS-TIA）：feasibility and effects[J]. Lancet Neurol，2007，6（11）：953-960.
[5] WARDLAW J，BRAZZELLI M，MIRANDA H，et al. An assessment of the cost-effectiveness of magnetic resonance，including diffusion-weighted imaging，in patients with transient ischaemic attack and minor stroke：a systematic review，meta-analysis and economic evaluation[J]. Health Technol Assess，2014，18（27）：1-368.
[6] KLEINDORFER D O，TOWFIGHI A，CHATURVEDI S，et al. 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack：a guideline from the American Heart Association/American Stroke Association[J/OL]. Stroke，2021，52（7）：e364-e467[2023-07-21]. https://doi.org/10.1161/STR.0000000000000375.
[7] H BUCK B，AKHTAR N，ALROHIMI A，et al.
Stroke mimics incidence，aetiology，clinical features and treatment[J]. Ann Med，2021，53（1）：420-436.
[8] WHITELEY W N，MACRAILD A，WANG Y，et al. Clinical diagnosis and magnetic resonance imaging in patients with transient and minor neurological symptoms：a prospective cohort study[J]. Stroke，2022，53（11）：3419-3428.
[9] WANG Y，WANG Y，ZHAO X，et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack[J]. N Engl J Med，2013，369（1）：11-19.
[10] JOHNSTON S C，EASTON J D，FARRANT M，et al. Clopidogrel and Aspirin in acute ischemic stroke and high-risk TIA[J]. N Engl J Med，2018，379（3）：215-225.
[11] JOHNSTON S C，AMARENCO P，DENISON H，et al. Ticagrelor and Aspirin or Aspirin alone in acute ischemic stroke or TIA[J]. N Engl J Med，2020，383（3）：207-217.
[12] AMARENCO P，LABREUCHE J，LAVALLÉE P C. Patients with transient ischemic attack with ABCD2<4
can have similar 90-day stroke risk as patients with transient ischemic attack with ABCD2≥4[J]. Stroke，2012，43（3）：863-865.
[13] PAN Y S，CHEN W Q，XU Y，et al. Genetic polymorphisms and clopidogrel efficacy for acute ischemic stroke or transient ischemic attack：a systematic review and meta-analysis[J]. Circulation，2017，135（1）：21-33.
[14] WANG Y J，MENG X，WANG A X，et al. Ticagrelor versus Clopidogrel in CYP2C19 loss-of-function carriers with stroke or TIA[J]. N Engl J Med，2021，385（27）：2520-2530.
[15] ROTHWELL P M，GUTNIKOV S A，WARLOW C P，et al. Reanalysis of the final results of the European Carotid Surgery Trial[J]. Stroke，2003，34（2）：514-523.
[16] BONATI L H，LYRER P，EDERLE J，et al. Percutaneous transluminal balloon angioplasty and stenting for carotid artery stenosis[J/OL]. Cochrane Database Syst Rev，2012（9）：CD000515[2023-07-21]. https://doi.org/10.1002/14651858.CD000515.pub4.
[17] International Carotid Stenting Study investigators，EDERLE J，DOBSON J，et al. Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis（International Carotid Stenting Study）：an interim analysis of a randomised controlled trial[J]. Lancet，2010，375（9719）：985-997.
[18] BONATI L H，DOBSON J，FEATHERSTONE R L，et al. Long-term outcomes after stenting versus endarterectomy for treatment of symptomatic carotid stenosis：the International Carotid Stenting Study（ICSS）randomised trial[J]. Lancet，2015，385（9967）：529-538.
[19] RANTNER B，GOEBEL G，BONATI L H，et al. The risk of carotid artery stenting compared with carotid endarterectomy is greatest in patients treated within 7 days of symptoms[J/OL]. Journal of Vascular Surgery，2013，57（3）：619-626. e2; discussion 625-626[2023-07-21]. https://doi.org/10.1016/j.jvs.2012.08.107.